# Tumor Mutational Burden, Liquid Biopsy, Angiogenic Factors and DCE-MRI Perfusion in HPV-Negative Oropharyngeal Cancer

> **NCT07407205** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Institute of Oncology Ljubljana** · enrollment: 30 (estimated)

## Conditions studied

- Oropharyngeal Squamous Cell Carcinoma
- Oropharyngeal HPV Squamous Cell Carcinoma

## Interventions

- **PROCEDURE:** Concurrent Chemoradiotherapy
- **DIAGNOSTIC_TEST:** Dynamic Contrast-Enhanced MRI Perfusion (DCE-MRI)

## Key facts

- **NCT ID:** NCT07407205
- **Lead sponsor:** Institute of Oncology Ljubljana
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-06-10
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07407205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07407205, "Tumor Mutational Burden, Liquid Biopsy, Angiogenic Factors and DCE-MRI Perfusion in HPV-Negative Oropharyngeal Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07407205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*